Medtronic (2M6.F) traded down -0.35 % during a 24 hours period ending at 10:00 AM Central Europe on Wednesday 28th. One Medtronic stock can currently be bought for about EUR 83.6 on popular exchanges. Current supply of Medtronic stocks is 1.3 bn. Medtronic has a current market capitalization of EUR 107.9 bn and approximately EUR 27.8 k worth of Medtronic was traded on exchanges in the last 24 hours. Since last month end, Medtronic has traded 7.31 % up. Simple moving average of last 200 days is at EUR 76.07. The highest price of past 52 weeks was recorded at EUR 91.45 on 11/26/2025. 52 weeks low was at EUR 63.02 on 06/02/2026.

Summary of the latest news for Medtronic

MEDTRONIC PLC is not the focus of the recent news items. The available reports discuss developments in epilepsy therapeutics, market growth expectations, and the involvement of former Medtronic executives in unrelated companies. No direct corporate actions or financial updates concerning MEDTRONIC PLC are mentioned.

Here is how related stocks have performed in the past 24 hours:

  • Kingspan (KRX.IR) traded up 3.75 % and now trades at EUR 95.3. Kingspan has a market capitalisation of EUR 16.1 bn. Current price/earnings ratio for Kingspan is 23.61.

  • Bank Of Ireland (BIRG.IR) traded flat 0 % and now trades at EUR 18.82. Bank Of Ireland has a market capitalisation of EUR 16.8 bn. Bank Of Ireland has a current price to earnings ratio of 14.89.

  • Aercap (AER) traded up 1.47 % and now trades at USD 150.05. Current market capitalisation for Aercap is USD 22.9 bn. Aercap has a current price to earnings ratio of 7.27. Aercap Holdings, a company that leases aircraft, ships, and other high‑value assets, has been cited in recent coverage by investors from Seawolf Capital. Those investors have expressed a preference for leasing models whose underlying assets have structural supply constraints and longer useful lives, contrasting Aercap’s business with that of a high‑capital, GPU‑based AI‑compute provider that has faced liquidity concerns. While the analysts see potential in Aercap’s asset‑heavy model, they note that its financial position is still fragile, with significant debt and limited cash flow generation. Market observers are watching whether Aercap can sustain its capital requirements and secure favourable financing conditions as it competes for a growing base of leasing customers. The discussion underscores the broader scrutiny of asset‑intensive leasing firms’ ability to convert contractual revenue into cash sufficient to cover operating, depreciation and financing costs.

  • Te Connectivity (TEL1N.MX) traded up 2.35 % and now trades at MXN 3,612.81. Current market capitalisation for Te Connectivity is MXN 1 trillions. Current price/earnings ratio for Te Connectivity is 18.83.

  • Pdd Holdings Inc (PDD) traded up 0.35 % and now trades at USD 78.4. Current market capitalisation for Pdd Holdings Inc is USD 111.2 bn. Pdd Holdings Inc has a current price to earnings ratio of 9.4. PDD Holdings Inc., the parent of the fast‑fashion platform Temu, remains a notable name in discussions of China’s internet sector, although recent coverage has focused largely on its sister brand Shein and broader regulatory dynamics. Analysts highlight that Shein’s listing in Hong Kong has drawn attention to the challenges faced by ultra‑fast fashion retailers, including tariff uncertainty, supply‑chain scrutiny and thin profit margins. The company’s market performance has been volatile, with a sharp decline in operating income reported for the first half of the current fiscal year and a significant drop in share price the following day. PDD Holdings, while benefiting from Shein’s visibility, is noted for its lower earnings visibility and the potential for its margins to be squeezed by similar headwinds affecting the broader sector. Overall, the market view suggests cautious optimism, tempered by concerns over cost pressures and the sustainability of high‑volume, low‑price retail models.

About Medtronic

Medtronic PLC is a health care equipment and supply company with its main operations in Dublin, Ireland. The company specializes in developing therapeutic and diagnostic medical products. Their principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. These products are sold globally.